Literature DB >> 20132991

Is there a CSF biomarker profile related to depression in elderly women?

Pia Gudmundsson1, Ingmar Skoog, Margda Waern, Kaj Blennow, Henrik Zetterberg, Lars Rosengren, Deborah Gustafson.   

Abstract

In light of our previous observation of higher levels of cerebrospinal fluid (CSF) amyloid beta-42 (Abeta42) and CSF/serum albumin ratio in major depressive disorder (MDD), we analyzed two additional CSF biomarkers reflecting neurodegeneration-neurofilament protein light (NFL) and glial fibrillary acidic protein (GFAp)-in relationship to prevalent geriatric depression. Neuropsychiatric, physical, and lumbar puncture examinations, with DSM-III-R-based depression diagnoses and measurement of CSF levels of NFL and GFAp, were evaluated among a population-based sample of 78 elderly women (mean age, 73.9+/-3.2 years) without dementia for at least 10 years after CSF collection. Eleven (13.1%) women had MDD, and higher levels of NFL compared with women without depression. A multivariate model including age, NFL, Abeta42 and the CSF/serum albumin ratio showed that each biomarker was independently and positively associated with MDD, and that this biomarker profile explained more variation in the model compared with single or combined biomarkers. A CSF profile with higher levels of NFL, Abeta42, and CSF/serum albumin ratio may indicate neuropathological and vascular events in depression etiology. This contrasts with the well-characterized pattern of low Abeta42, higher CSF/serum albumin ratio, and higher NFL in Alzheimer's disease. Copyright (c) 2008 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132991     DOI: 10.1016/j.psychres.2008.11.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.

Authors:  Davide Bruno; Nunzio Pomara; Jay Nierenberg; James C Ritchie; Michael W Lutz; Henrik Zetterberg; Kaj Blennow
Journal:  Exp Gerontol       Date:  2011-10-01       Impact factor: 4.032

2.  Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype.

Authors:  Breno Satler Diniz; Charles F Reynolds; Etienne Sibille; Chien-Wei Lin; George Tseng; Francis Lotrich; Howard J Aizenstein; Meryl A Butters
Journal:  Am J Geriatr Psychiatry       Date:  2016-08-31       Impact factor: 4.105

3.  Brain neurotoxic amyloid-beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets.

Authors:  Nunzio Pomara; John J Sidtis
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.

Authors:  Nunzio Pomara; Davide Bruno; Antero S Sarreal; Raymundo T Hernando; Jay Nierenberg; Eva Petkova; John J Sidtis; Thomas M Wisniewski; Pankaj D Mehta; Domenico Pratico; Henrik Zetterberg; Kaj Blennow
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

Review 5.  Glutamate Efflux across the Blood-Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System.

Authors:  Benjamin Fredrick Gruenbaum; Alexander Zlotnik; Amit Frenkel; Ilya Fleidervish; Matthew Boyko
Journal:  Metabolites       Date:  2022-05-20

Review 6.  Blood-Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder.

Authors:  Shusheng Wu; Yuye Yin; Longfei Du
Journal:  Cell Mol Neurobiol       Date:  2021-10-12       Impact factor: 4.231

7.  Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Maike Michel; Bernd L Fiebich; Hanna Kuzior; Sophie Meixensberger; Benjamin Berger; Simon Maier; Kathrin Nickel; Kimon Runge; Dominik Denzel; Benjamin Pankratz; Miriam A Schiele; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

8.  Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide.

Authors:  Katalin Adrienna Kékesi; Gábor Juhász; Attila Simor; Péter Gulyássy; Eva Mónika Szegő; Eva Hunyadi-Gulyás; Zsuzsanna Darula; Katalin F Medzihradszky; Miklós Palkovits; Botond Penke; András Czurkó
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

9.  Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study.

Authors:  Claire Paquet; Eloi Magnin; David Wallon; Anne-Cécile Troussière; Julien Dumurgier; Alain Jager; Frank Bellivier; Elodie Bouaziz-Amar; Frédéric Blanc; Emilie Beaufils; Carole Miguet-Alfonsi; Muriel Quillard; Susanna Schraen; Florence Pasquier; Didier Hannequin; Philippe Robert; Jacques Hugon; François Mouton-Liger
Journal:  Alzheimers Res Ther       Date:  2016-06-13       Impact factor: 6.982

10.  Sex difference in cerebrospinal fluid/blood albumin quotients in patients with schizophreniform and affective psychosis.

Authors:  Sophie Meixensberger; Karl Bechter; Rick Dersch; Bernd Feige; Simon Maier; Miriam A Schiele; Kimon Runge; Dominik Denzel; Kathrin Nickel; Derek Spieler; Horst Urbach; Harald Prüss; Katharina Domschke; Ludger Tebartz van Elst; Dominique Endres
Journal:  Fluids Barriers CNS       Date:  2020-11-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.